📉 cAMP-targeting pharmacological treatments also mimic and reverse srrm3-dependent transcriptional signatures, including immediate early gene downregulation. Combined with persistent AP1/CREB motif occupancy, it all suggests a longer-term adaptation to sustained neuronal hyperactivity. 9/9